Literature DB >> 6088960

Coxsackievirus B3 persistence and myocarditis in NFR nu/nu and +/nu mice.

D P Schnurr, N J Schmidt.   

Abstract

NFR nude (nu/nu) and euthymic (+/nu) littermates were infected with coxsackievirus B3 (CBV-3) and assayed for virus persistence in the heart, pancreas and spleen, for development of myocarditis and for antibody production. The virus grew to higher titer and persisted longer in hearts of nu/nu mice. In both types of mice there was comparable myocarditis with a mononuclear cell inflammatory response, and there was some evidence of chronic lesions for up to 21 days in +/nu and 28 days in nu/nu mice. Antibody of the IgM class was present at 7 days in both strains of mice. Thereafter, +/nu mice produced high titers of virus-specific IgG antibody, while nu/nu mice produced little or no viral IgG antibody. The persistence of virus for up to 28 days in NFR nude mice is longer than has been reported previously, and offers an opportunity for further study of the role of T-cells in virus persistence and myocarditis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088960     DOI: 10.1007/bf02123563

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  10 in total

1.  Thymus dependence of viral antigens.

Authors:  W Burns; L C Billups; A L Notkins
Journal:  Nature       Date:  1975-08-21       Impact factor: 49.962

2.  Limited persistence of viral antigen in coxsackievirus B3 induced heart disease in mice.

Authors:  T G Roesing; B J Landau; R L Crowell
Journal:  Proc Soc Exp Biol Med       Date:  1979-03

3.  Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease.

Authors:  J F Woodruff; J J Woodruff
Journal:  J Immunol       Date:  1974-12       Impact factor: 5.422

4.  Coupling of enzymes to proteins with glutaraldehyde. Use of the conjugates for the detection of antigens and antibodies.

Authors:  S Avrameas
Journal:  Immunochemistry       Date:  1969-01

5.  Visual reading of enzyme immunofluorescence assays for human cytomegalovirus antibodies.

Authors:  B Forghani; J Dennis; N J Schmidt
Journal:  J Clin Microbiol       Date:  1980-11       Impact factor: 5.948

6.  Coxsackie B3 myocarditis in athymic mice.

Authors:  J A Robinson; J B O'Connell; L M Roeges; E O Major; R M Gunnar
Journal:  Proc Soc Exp Biol Med       Date:  1981-01

7.  Induction of T- and B-lymphocyte responses in antigenically stimulated athymic mice.

Authors:  G M Beattie; S M Baird; J S Lipsick; R A Lannom; N O Kaplan
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

8.  Alterations in coxsackievirus B4 heart muscle disease in ICR Swiss mice by anti-thymocyte serum.

Authors:  R Khatib; G Khatib; J L Chason; A M Lerner
Journal:  J Gen Virol       Date:  1983-01       Impact factor: 3.891

9.  Serum immunoglobulins in nude mice and their heterozygous littermates during ageing.

Authors:  J G Mink; J Radl; P van den Berg; J J Haaijman; M J van Zwieten; R Benner
Journal:  Immunology       Date:  1980-08       Impact factor: 7.397

10.  Myocardial changes after infection with Coxsackie virus B3 in nude mice.

Authors:  I Hashimoto; T Komatsu
Journal:  Br J Exp Pathol       Date:  1978-02
  10 in total
  6 in total

Review 1.  Innate and adaptive immune responses against picornaviruses and their counteractions: An overview.

Authors:  Andreas Dotzauer; Leena Kraemer
Journal:  World J Virol       Date:  2012-06-12

Review 2.  Type B coxsackieviruses and their interactions with the innate and adaptive immune systems.

Authors:  Christopher C Kemball; Mehrdad Alirezaei; J Lindsay Whitton
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Enteroviral infection in end stage dilated cardiomyopathy.

Authors:  V Wiegand; S Tracy; N Chapman; C Wucherpfennig
Journal:  Klin Wochenschr       Date:  1990-09-14

4.  Coxsackievirus B-3 selection of virus resistant Buffalo green monkey kidney cells and chromosome analysis of parental and resistant cells.

Authors:  Y Cao; K H Walen; D Schnurr
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

5.  Derivation and characterization of an efficiently myocarditic reovirus variant.

Authors:  B Sherry; F J Schoen; E Wenske; B N Fields
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Viral persistence during the developmental phase of Coxsackievirus B1-induced murine polymyositis.

Authors:  P E Tam; A M Schmidt; S R Ytterberg; R P Messner
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.